Primergy Solar Secures up to $200M Revolving Credit Facility from Rabobank
Funding supports expanded in ERCOT, MISO, PJM and WECC making Primergy’s project portfolio exceed 14…
Month: December 2022
CMCT Announces Redemption in Full of Series L Preferred Stock
DALLAS–(BUSINESS WIRE)–Creative Media & Community Trust Corporation (NASDAQ: CMCT and TASE: CMCT-L) announced today that,…
Outlook Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ISELIN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
Nykode Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
OSLO, Norway, Dec. 23, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage…
FREYR Battery Appoints Executive to Lead Global Corporate Development and U.S. Execution
NEW YORK & OSLO & LUXEMBOURG–(BUSINESS WIRE)–FREYR Battery (NYSE: FREY) (“FREYR” or “the Company”), a…
United States Used Car Market Outlook Report 2022-2026 – Driven by An Influx of Digital Players Along With Consumer Demand for Personal Mobility and Affordable Pricing – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “USA Used Car Market Outlook to 2026 – Driven by An Influx of…
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention based on a novel…
Bavarian Nordic Enters Agreement Valued up to USD 83 Million with the U.S. Department of Defense to Further Advance the Development of Equine Encephalitis Virus Vaccine
Total considerations of up to USD 83 million with the majority secured for Phase 2…
DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial
Montrouge, France, December 23, 2022 DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on…
Basilea announces regulatory approval of antifungal Cresemba® (isavuconazole) in Japan
Japanese regulatory authority granted marketing authorization to Basilea’s license partner, Asahi Kasei Pharma Intravenous and…
Valneva Completes BLA Submission to U.S. FDA for its Single-Shot Chikungunya Vaccine Candidate
Saint-Herblain (France), December 23, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
LBank Exchange Will List DiDimCoin (DDC) on December 23, 2022
Internet City, Dubai–(Newsfile Corp. – December 23, 2022) – LBank Exchange, a global digital asset…
FLAG Token (FLAG) Is Now Available for Trading on LBank Exchange
Internet City, Dubai–(Newsfile Corp. – December 23, 2022) – LBank Exchange, a global digital asset…
Shares of Major Global Medical Device Manufacturer OrbusNeich Medical Group Commence Trading on the Main Board of The Stock Exchange of Hong Kong
HONG KONG, Dec 23, 2022 – (ACN Newswire) – Shares of OrbusNeich Medical Group Holdings…
‘Switching On the SUN’ – Samaiden Officially Turns on First Power Generation Facility at Sunway Nexis
PETALING JAYA, Malaysia, Dec 23, 2022 – (ACN Newswire) – Samaiden Group Berhad (Bursa: SAMAIDEN,…
Fujitsu to provide AIST’s “ABCI,” the world’s largest computational infrastructure for AI processing via Fujitsu Computing as a Service (CaaS)
TOKYO, Dec 23, 2022 – (JCN Newswire) – Fujitsu today announced that it will start…
Mesoblast and Oaktree Extend Availability Period of Undrawn Tranches of Financing Facility
NEW YORK, Dec. 22, 2022 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Finxeed Announces $10 Million Strategic Investment from DBank (Chain Bank Group) to Launch the World’s First Digital Asset Prop Firm
Kuala Lumpur, Malaysia–(Newsfile Corp. – December 22, 2022) – Finxeed, the decentralized credibility scoring platform,…
Delaware Investments® National Municipal Income Fund Announces Board Approval of New Investment Management Agreement with abrdn Inc. and Nomination of Four New Trustees
PHILADELPHIA–(BUSINESS WIRE)–Today, Delaware Investments National Municipal Income Fund (the “Fund”), a New York Stock Exchange…
Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
– Similar clinical remission rates observed in patients receiving AMT-101 monotherapy compared to placebo at…